Paid Clinical Trials Olathe
Discover 764 paid clinical trials in Olathe, Kansas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With AsthmaEvaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma
Sponsor:
AstraZeneca
Location:
Code:
NCT06307665
Conditions
Asthma
Eligibility Criteria
Sex: All
Age: 12 - 17
Healthy Volunteers: Not accepted
Interventions
BDA MDI
AS MDI
A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung CancerA Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer
Sponsor:
Iovance Biotherapeutics, Inc.
Location:
Code:
NCT05361174
Conditions
Unresectable Melanoma
Metastatic Melanoma
Stage III Non-small Cell Lung Cancer
Stage IV Non-small Cell Lung Cancer
Eligibility Criteria
Sex: All
Age: 18 - 70
Healthy Volunteers: Not accepted
Interventions
IOV-4001
Testing the Use of Steroids and Tyrosine Kinase Inhibitors With Blinatumomab or Chemotherapy for Newly Diagnosed BCR-ABL-Positive Acute Lymphoblastic Leukemia in AdultsTesting the Use of Steroids and Tyrosine Kinase Inhibitors With Blinatumomab or Chemotherapy for Newly Diagnosed BCR-ABL-Positive Acute Lymphoblastic Leukemia in Adults
Sponsor:
National Cancer Institute (NCI)
Location:
Code:
NCT04530565
Conditions
B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Biospecimen Collection
Blinatumomab
Bone Marrow Aspiration and Biopsy
Cyclophosphamide
Cytarabine
Neoadjuvant TIL- and Response-Adapted Chemoimmunotherapy for TNBCNeoadjuvant TIL- and Response-Adapted Chemoimmunotherapy for TNBC
Sponsor:
University of Kansas Medical Center
Location:
Code:
NCT05645380
Conditions
Triple Negative Breast Cancer
Breast Cancer
Eligibility Criteria
Sex: Female
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Carboplatin
Docetaxel
Doxorubicin
Cyclophosphamide
Pembrolizumab
Safety and Efficacy Study of an Ophthalmic Solution in Patients With Age-Related CataractSafety and Efficacy Study of an Ophthalmic Solution in Patients With Age-Related Cataract
Sponsor:
Chakshu Research, Inc.
Location:
Code:
NCT00793091
Conditions
Cataract
Eligibility Criteria
Sex: All
Age: 50 - 70+
Healthy Volunteers: Not accepted
Interventions
C-KAD Ophthalmic Solution
Placebo
Human/Machine Interface: What the HeartMate 3 ® Device Tells Us About the FutureHuman/Machine Interface: What the HeartMate 3 ® Device Tells Us About the Future
Sponsor:
International Consortium of Circulatory Assist Clinicians
Location:
Code:
NCT06039176
Conditions
LVAD
Frailty
GI Bleed
Right Heart Failure
Infections
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
HeartMate 3 (R) left ventricular assist device
Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable CancersTesting the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable Cancers
Sponsor:
National Cancer Institute (NCI)
Location:
Code:
NCT05803382
Conditions
Metastatic Colorectal Carcinoma
Metastatic Malignant Solid Neoplasm
Stage IV Colorectal Cancer AJCC v8
Unresectable Colorectal Carcinoma
Unresectable Malignant Solid Neoplasm
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
BET Bromodomain Inhibitor ZEN-3694
Biopsy
Biospecimen Collection
Capecitabine
Computed Tomography
A RAndomizeD Intervention for Cardiovascular and Lifestyle Risk Factors in Prostate Cancer PatientsA RAndomizeD Intervention for Cardiovascular and Lifestyle Risk Factors in Prostate Cancer Patients
Sponsor:
McMaster University
Location:
Code:
NCT03127631
Conditions
Prostate Cancer
Cardiovascular Disease
Eligibility Criteria
Sex: Male
Age: 45+
Healthy Volunteers: Not accepted
Interventions
Nutrition
Exercise
Smoking cessation
Statin (such as Simvastatin, Atorvastatin, Rosuvastatin, Pravastatin)
ACE inhibitor
Study of ALXN2220 Versus Placebo in Adults With ATTR-CMStudy of ALXN2220 Versus Placebo in Adults With ATTR-CM
Sponsor:
Alexion Pharmaceuticals, Inc.
Location:
Code:
NCT06183931
Conditions
Transthyretin Amyloid Cardiomyopathy
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
ALXN2220
Placebo
Continuous Monitoring and Control of HypoglycemiaContinuous Monitoring and Control of Hypoglycemia
Sponsor:
DexCom, Inc.
Location:
Code:
NCT03340831
Conditions
Diabetes
Eligibility Criteria
Sex: All
Age: 2+
Healthy Volunteers: Not accepted
Interventions
Continuous Glucose Monitoring (CGM)